Difference between revisions of "Suramin (Antrypol)"
Jump to navigation
Jump to search
(Created page with "==Mechanism of action== Antiparasitic with mechanism of action unclear. ==Diseases for which it was used== *Prostate cancer ==History of changes in FDA indication== *Thi...") |
m |
||
| Line 7: | Line 7: | ||
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
*This drug is not FDA approved. Of note, it was investigated in prostate cancer but utility was not proven and investigations have been discontinued. | *This drug is not FDA approved. Of note, it was investigated in prostate cancer but utility was not proven and investigations have been discontinued. | ||
| + | |||
| + | ==Also known as== | ||
| + | *'''Brand name:''' Antrypol | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
[[Category:Stub]] | [[Category:Stub]] | ||
Revision as of 12:39, 4 December 2022
Mechanism of action
Antiparasitic with mechanism of action unclear.
Diseases for which it was used
History of changes in FDA indication
- This drug is not FDA approved. Of note, it was investigated in prostate cancer but utility was not proven and investigations have been discontinued.
Also known as
- Brand name: Antrypol